MIG
AZN icon

Mariner Investment Group’s AstraZeneca AZN Stock Holding History

Mariner Investment Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-67,250
Closed -$32K – 89
2016
Q2 		$32K Buy
+67,250
New +$3.91M 0.01% 128

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Mariner Investment Group's AZN Position: Q3 2016 in Review

Mariner Investment Group sold out of AstraZeneca (AZN) in Q3 2016, closing a stake of 12,750 shares — an estimated $770K sold.

Mariner Investment Group first reported a position in AZN in Q4 2014 and held it in 5 quarters. The position peaked at $1.86M in Q4 2014. 450 funds tracked by Wall St. Rank hold AZN as of Q3 2016.

  • Mariner Investment Group reported no remaining AstraZeneca position as of Q3 2016 after selling out during the quarter.
  • Mariner Investment Group sold 12,750 AstraZeneca shares in Q3 2016, an estimated $770K.
  • Mariner Investment Group first reported a position in AstraZeneca in Q4 2014 and held it in 5 quarters.
  • Mariner Investment Group's AstraZeneca position peaked at $1.86M in Q4 2014.
  • 450 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.